Previous Article | Next Article 
Infect Immun, March 1998, p. 1233-1236, Vol. 66, No. 3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Transforming Growth Factor
and
Immunosuppression in Experimental Visceral Leishmaniasis
Virmondes
Rodrigues Jr.,1,*
João
Santana da
Silva,2 and
Antonio
Campos-Neto3,4,*
Immunology Laboratory, Medical School of
Triângulo Mineiro, Uberaba,1 MG,
Department of Immunology, Medical School of Ribeirão
Preto, Ribeirão Preto,2 SP, and
Medical School of Itajubá,3 MG,
Brazil, and
Infectious Disease Research Institute, Seattle,
Washington 981044
Received 26 September 1997/Returned for modification 13 November
1997/Accepted 3 December 1997
 |
ABSTRACT |
Hamsters infected with Leishmania donovani develop a
disease similar to human kala-azar. They present
hypergammaglobulinemia, and their T cells do not respond to parasite
antigens. This unresponsiveness has been primarily ascribed to defects
in antigen-presenting cells (APCs), because these cells are unable to
stimulate proliferation of parasite-specific T cells from immunized
animals. In this study, we show that APCs (adherent spleen cells) from
L. donovani-infected hamsters produce high levels of the
inhibitory cytokine transforming growth factor
(TGF-
).
Immunohistochemical studies with an anti-TGF-
monoclonal antibody
(MAb) showed that this cytokine is abundantly produced in vivo by the
spleen cells of infected animals. In addition, high levels of TGF-
are produced in vitro by infected hamster cells, either spontaneously
or after stimulation with parasite antigen or lipopolysaccharide.
Furthermore, in vivo-infected adherent cells obtained from spleens of
L. donovani-infected hamsters caused profound inhibition of
the in vitro antigen-induced proliferative response of lymph node cells
from hamsters immunized with leishmanial antigens. Moreover, this
inhibition was totally abrogated by the anti-TGF-
MAb. These results
suggest that the immunosuppression observed in visceral leishmaniasis
is, at least in part, due to the abundant production of TGF-
during
the course of the infection.
 |
TEXT |
The protozoa of the genus
Leishmania are parasites responsible for diseases of major
relevance in tropical and subtropical areas of the world
(10, 14). In mammals, these parasites are strictly
intracellular and infect mononuclear phagocytic and dendritic cells.
The involvement of the immune system in human visceral leishmaniasis is
characterized by increased serum immunoglobulin levels with high titers
of antileishmania antibodies (6, 16, 17), hepatomegaly,
splenomegaly, adenomegaly, negative skin test for leishmania antigens,
and the absence of a proliferative response of peripheral blood
mononuclear cells to Leishmania donovani antigens
(20). The cause of this impaired specific immune response may be ascribed to any of the cell types involved in the immune response.
Hamsters have been used as a good model for the study of visceral
leishmaniasis (4, 5, 7, 18, 22). After intracardiac or
intraperitoneal infection, they present a progressive disease similar
to human kala-azar, developing hypergammaglobulinemia due to B-cell
polyclonal activation and the absence of a T-cell proliferative
response to parasite antigens (4). The latter dysfunction
has been attributed to the inability of the infected antigen-presenting
cells (APCs) to stimulate the specific T cells (9, 13, 15,
21).
Transforming growth factor
(TGF-
) is a pleiotropic cytokine
involved in many functions of resident tissue cells, but it largely
inhibits some activity of immune cells. TGF-
can mediate immunosuppression by inhibiting interleukin 2-dependent T- and B-cell
proliferation and interleukin 2-dependent immunoglobulin production by
B cells (11, 12) and macrophage activation (8, 23). In addition, TGF-
has been implicated as a cytokine that promotes the in vitro replication and survival of leishmania within the
macrophages and is an important factor for determining in vivo
susceptibility to experimental infection of mice with species of
leishmania that cause cutaneous and mucocutaneous infections in humans
(1-3).
Most of the alterations induced by TGF-
on the cellular immune
response resemble those of our previous observation in the hamster
infected with L. donovani (21). These studies
indicated that the impairment of the immune response was caused by a
defect in the antigen presentation by the APCs of L. donovani-infected animals.
In the present work, we extend these studies, aiming to investigate the
mechanism involved in this defect. We focused on the immunoregulatory
effect of TGF-
on the APCs (adherent spleen cells) from L. donovani-infected hamsters. To achieve this proposal, we initially
had to validate a standard human TGF-
biological assay
(19) for the hamster system. This validation was important because of the unavailability of an anti-hamster TGF-
antibody. Because of the evolutionary conservation of TGF-
, we tested the standard proliferation inhibition assay of CCL64 cells (mink lung epithelial cells) in the absence and in the presence of the mouse anti-human TGF-
monoclonal antibody (MAb) 1D11.16 (Celtrix
Pharmaceuticals, Inc., Santa Clara, Calif.). Normal hamster spleen
cells were stimulated with lipopolysaccharide (1 µg/ml), and the
presence of TGF-
in the culture supernatants was analyzed 24 and 48 h later. Regardless of the incubation time, the culture
supernatants caused, in a dose response manner, inhibition of the
proliferation of the CCL64 cells ranging from 100% to no inhibition
(not shown). More importantly, this activity was totally
abrogated by the 1D11.16 MAb, therefore validating the use of this
assay for the hamster system.
To evaluate the production of TGF-
in L. donovani-infected hamsters, spleen cells were obtained from
noninfected inbred CB hamsters (Charles River, Mass.) and from CB
hamsters at 40 and 60 days after infection with 10 × 106 amastigote forms of L. donovani (amastigotes
were freshly isolated from spleens of infected hamsters). The
spontaneous production of TGF-
was measured in the culture
(Dulbecco's modified Eagle's medium [DMEM] plus 2% fetal calf
serum [FCS]) supernatants after 48 h of incubation at 37°C. It
is clear from the results shown in Fig. 1
that the spleen cells from hamsters infected for 40 or 60 days produced
as much as 20 and 34 times more TGF-
, respectively, than was
produced by the cells from age- and sex-matched syngeneic normal
hamsters. In addition, in vitro stimulation of these cells with 10 µg
of a soluble L. donovani lysate antigen (SLdA) per ml
(21) augmented two to three times the production of TGF-
by the spleen cells from either noninfected or infected hamsters. These
results are consistent with previous observations that showed that
TGF-
is produced by murine macrophages exposed to Leishmania braziliensis (1, 2). However, stimulation of the
hamster cells with 1 µg of lipopolysaccharide (Pierce Chemical
Company, Rockford, Ill.) augmented more than 10 times the production of TGF-
by the cells from noninfected animals and less than 3 times the
production for the cells of hamsters infected for 40 or 60 days (not
shown), thus suggesting an exacerbated in vivo prestimulation of the
hamster spleen cells by the infectious process.

View larger version (11K):
[in this window]
[in a new window]

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Spontaneous production of TGF- by spleen cells of
noninfected or L. donovani-infected hamsters. Spleen
mononuclear cells from hamsters infected for 40 and 60 days and from
noninfected animals were suspended at 5 × 106
cells/ml in RPMI medium supplemented with 2% FCS plus antibiotics and
cultured at 37°C for 48 h. Supernatants were analyzed for native
TGF- (nonacidified) activity (A) with the proliferation inhibition
assay of CCL64 cells (mink lung epithelial cells). CCL64 cells were
cultured for 30 h in DMEM supplemented with 2% FCS in the
presence of serial dilutions of supernatants. Proliferation was
measured by incorporation of [3H]thymidine added during
the last 6 h of incubation. An anti-TGF- -neutralizing MAb was
used to confirm the specificity of the assay. Quantification of TGF-
was performed with a standard curve obtained with recombinant human
TGF- (B). Bars represent the arithmetic mean of the results from at
least three hamsters per group, and lines give the standard errors.
|
|
To demonstrate the in vivo production of TGF-
, we performed an
immunohistochemical assay with the 1D11.16 MAb. Spleen sections (4 µm
thick) from L. donovani-infected and noninfected animals were fixed with acetone and incubated with the 1D11.16 MAb for 4 h
at room temperature. The sections were washed four times with phosphate-buffered saline (PBS) containing 0.05% Tween 20 and incubated with a rabbit anti-mouse immunoglobulin-peroxidase conjugate (Pierce Chemical Company) for 1 h at room temperature. The slides were washed four times and incubated with 1 mg of diaminobenzidine (Pierce Chemical Company) per ml and 0.01% hydrogen peroxide in 100 mM
Tris-HCl (pH 7.2). The results (Fig. 2)
show massive production of TGF-
in the spleens from the infected
animals, largely present both in the cytoplasm of mononuclear cells and
in the intercellular space. In contrast, the presence of this cytokine
was barely noticeable in the spleens from age- and sex-matched
syngeneic noninfected controls.

View larger version (140K):
[in this window]
[in a new window]
|
FIG. 2.
Detection of TGF- production in vivo in spleens of
L. donovani-infected hamsters. Spleen sections (4 µm
thick) from noninfected hamsters (A) and from hamsters infected with
L. donovani for 60 days (B) were fixed with acetone and
incubated with anti-TGF- MAb 1D11.16, washed four times with PBS
plus 0.05% Tween 20, and incubated with a rabbit anti-mouse
immunoglobulin-peroxidase conjugate for 1 h at room temperature.
The slides were washed and incubated with 1 mg of diaminobenzidine per
ml and 0.01% hydrogen peroxide in Tris-HCl (0.1 M [pH 7.2]). Brown
granules indicate the presence of TGF- in the spleens of infected
animals. Magnification, ×500.
|
|
We and others have previously shown that the antigen presentation by
L. donovani-infected cells is greatly impaired (9, 13,
15, 21). Because the spleen cells from L. donovani-infected hamsters produced large quantities of TGF-
,
we tested the possibility that the production of this antiproliferative
cytokine by infected cells was responsible for the observed inability
of these cells to perform antigen presentation. To investigate this
possibility, noninfected CB hamsters were initially immunized in the
footpad with SLdA in complete Freund's adjuvent, and the draining
lymph nodes were harvested 10 days later. Lymph node cells (2 × 105/well in 96-well flat-bottom microtiter culture plates)
were obtained and stimulated to proliferate with SLdA in the absence
and in the presence of adherent spleen cells obtained from either
noninfected or L. donovani-infected hamsters. Adherent
spleen cells were obtained by incubating mononuclear spleen cells
(5 × 105) for 2 h in the wells of 96-well
flat-bottom microtiter culture plates. Nonadherent cells were then
removed by three consecutive washes with RPMI medium plus 10% FCS. In
addition, some cultures received the 1D11.16 MAb or an isotype-matched
immunoglobulin control. Figure 3 shows
that adherent cells from the infected hamsters
inhibited practically 100% of the specific proliferative response of
the lymph node cells from L. donovani-immunized
animals. More importantly, the anti-TGF-
MAb 1D11.16 totally
restored the responsiveness of the lymph node cells to the leishmanial antigens, thus pointing to a strong participation of TGF-
as an
inhibitory cytokine produced by adherent spleen cells of L. donovani-infected hamsters. No inhibition of the proliferative response was observed when adherent spleen cells from noninfected hamsters were used. In addition, no restoration of the proliferation was achieved when an isotype-matched control of the 1D11.16 MAb was
added to the cell cultures (not shown). These results expand those
related to the L. donovani complex, with previous
observations pointing to a pathological role of TGF-
in the course
of infection of mice infected with dermotropic Leishmania
(1-3). However, in these studies, the inhibitory effect of
TGF-
appeared relatively early (a few days) after infection,
suggesting that this cytokine is involved in the regulation and
development of a pervasive immune response at the initiation of the
infection. In contrast, because in the present studies the involvement
of TGF-
was detected only late in the infection, it is more likely
that the role of this cytokine in visceral leishmaniasis is to maintain
or to exacerbate the characteristic immunosuppression observed in this
disease.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Inhibition of antigen-induced proliferative
response of lymph node cells from immunized hamsters by adherent spleen
cells from L. donovani-infected hamsters. CB hamsters were
immunized in the footpad with soluble L. donovani lysate
antigen in complete Freund's adjuvant, and the draining lymph nodes
were harvested 10 days later. Lymph node cells were obtained and
stimulated to proliferate with L. donovani antigens in the
absence of additional adherent spleen cells (Ln), in the presence of
adherent spleen cells obtained from noninfected hamsters (Ln + normal Ad) or from L. donovani-infected hamsters (Ln + infected Ad), or in the presence of adherent spleen cells obtained from
L. donovani-infected hamsters plus the anti-TGF- MAb
1D11.16 (Ln + infected Ad + anti-TGF- ). Cultures were
either nonstimulated (medium) or stimulated with 10 µg of SLdA, and
proliferation was measured by incorporation of
[3H]thymidine added during the last 6 h of
incubation in a 3-day assay. Bars represent the arithmetic mean of
triplicate cultures, and lines give the standard errors. The results
shown are representative of two independent experiments. One-way
analysis of variance was used to analyze the results. Statistical
significance was set up at P < 0.01. *,
P < 0.01 versus Ln + normal Ad or Ln + infected Ad + anti-TGF- .
|
|
 |
ACKNOWLEDGMENTS |
We thank Fundação de Ensino e Pesquisa de Uberaba for
financial support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address for Antonio
Campos-Neto: Infectious Disease Research Institute, 1124 Columbia St.,
Seattle, WA 98104-2015. Phone: (206) 667-5799. Fax: (206) 667-5715. E-mail: acampos{at}corixa.com. Mailing address for
Virmondes Rodrigues, Faculdade de Medicina do Triângulo Mineiro,
Laboratório de Immunologia, Rua Frei Paulino 30, Uberaba, MG
38025-180, Brazil. Phone: 55 34 312-7722. Fax: 55 34 312-6640. E-mail:
vrodrigues{at}mednet.com.br.
Editor: J. M. Mansfield
 |
REFERENCES |
| 1.
|
Barral, A.,
M. Barral-Netto,
E. C. Yong,
C. E. Brownell,
D. R. Twardzik, and S. G. Reed.
1993.
Transforming growth factor as a virulence mechanism for Leishmania braziliensis.
Proc. Natl. Acad. Sci. USA
90:3442-3446[Abstract/Free Full Text].
|
| 2.
| Barral, A., M. Teixeira, P. Reis, V. Vinhas, J. Costa, H. Lessa, A. L. Bittencourt, S. Reed, E. M. Carvalho,
and M. Barral-Netto. Transforming growth factor in human
cutaneous leishmaniasis. Am. J. Pathol. 147:947-954.
|
| 3.
|
Barral-Netto, M.,
A. Barral,
C. E. Brownell,
Y. A. Skeiky,
L. R. Ellingsworth,
D. R. Twardzik, and S. G. Reed.
1992.
Transforming growth factor in leishmania infection: a parasite escape mechanism.
Science
257:545-548[Abstract/Free Full Text].
|
| 4.
|
Bunn-Moreno, M.,
E. D. Madeira,
K. Miller,
J. A. Menezes, and A. Campos-Neto.
1985.
Hypergammaglobulinemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function.
Clin. Exp. Immunol.
59:427-434[Medline].
|
| 5.
|
Campos-Neto, A., and M. M. Bunn-Moreno.
1982.
Polyclonal B cell activation in hamsters infected with parasites of the genus Leishmania.
Infect. Immun.
38:871-876[Abstract/Free Full Text].
|
| 6.
|
Chaves, J., and R. G. Ferri.
1966.
Immunoglobulins in visceral leishmaniasis.
Rev. Inst. Med. Trop. São Paulo
8:225-227[Medline].
|
| 7.
|
Clinton, B. A.,
L. A. Stauber, and N. C. Palczuk.
1969.
Leishmania donovani. I. Antibody response to chicken ovalbumin by infected golden hamsters.
Exp. Parasitol.
25:171-180[Medline].
|
| 8.
|
Ding, A.,
C. F. Nathan,
J. Graycar,
R. Derynck,
D. J. Stuehr, and S. Srimal.
1990.
Macrophage deactivating factor and transforming growth factors 1, 2, and 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN- .
J. Immunol.
145:940-944[Abstract].
|
| 9.
|
Fruth, U.,
N. Solioz, and J. A. Louis.
1993.
Leishmania major interferes with antigen presentation by infected macrophages.
J. Immunol.
150:1857-1864[Abstract].
|
| 10.
|
Grimaldi, G., Jr., and R. B. Tesh.
1993.
Leishmaniasis of the New World: current concepts and implications for future research.
Clin. Microbiol. Rev.
6:230-250[Abstract/Free Full Text].
|
| 11.
|
Kehrl, J. H.,
A. B. Roberts,
L. M. Wakefield,
S. Jakowlew,
M. B. Sporn, and A. S. Fauci.
1986.
Transforming growth factor is an important immunomodulatory protein for human B lymphocytes.
J. Immunol.
137:3855-3860[Abstract].
|
| 12.
|
Kehrl, J. H.,
L. M. Wakefield,
A. B. Roberts,
S. Jakowlew,
M. Alvarez-Mon,
R. Derynck,
M. B. Sporin, and A. S. Fauci.
1986.
Production of transforming growth factor by human T lymphocytes and its potential role in the regulation of T cell growth.
J. Exp. Med.
163:1037-1050[Abstract/Free Full Text].
|
| 13.
|
Kima, P. E.,
L. Soong,
C. Chicarro,
N. H. Ruddle, and D. McMahon-Pratt.
1996.
Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells.
Eur. J. Immunol.
26:3163-3169[Medline].
|
| 14.
|
Laison, R., and J. J. Shaw.
1978.
Epidemiology and ecology of leishmaniasis in Latin America.
Nature
273:595-600[Medline].
|
| 15.
|
López, J. A.,
J. H. LeBowitz,
S. M. Beverly,
H.-G. Rammensee, and P. Overath.
1992.
Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages.
Eur. J. Immunol.
23:217-223.
|
| 16.
|
Manson-Bahr, P. E. C.
1961.
Immunity in kala-azar.
Trans. R. Soc. Trop. Med. Hyg.
55:550-555.
|
| 17.
|
Mayrink, W.,
F. G. Araujo, and P. A. Magalhães.
1967.
Fluorescent antibody test in visceral leishmaniasis.
Rev. Inst. Med. Trop. São Paulo
9:172-174[Medline].
|
| 18.
|
Nickol, A. D., and P. F. Bonventre.
1985.
Immunosuppression associated with visceral leishmaniasis of hamsters.
Parasite Immunol.
7:439-449[Medline].
|
| 19.
|
Ranchalis, J. E.,
L. Gentry,
S. M. Seyedin,
J. McPherson,
A. Purchio, and D. R. Twardzik.
1987.
Bone-derived and recombinant transforming growth factor are potent inhibitors of tumor cell growth.
Biochem. Biophys. Res. Commun.
148:783-789[Medline].
|
| 20.
|
Rezai, H. R.,
S. M. Ardehsli,
G. Armirhakimi, and A. Kharazmi.
1978.
Immunological features of kala-azar.
Am. J. Trop. Med. Hyg.
27:1079-1083.
|
| 21.
|
Rodrigues, V., Jr.,
J. S. Santana, and A. Campos-Neto.
1992.
Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.
Parasite Immunol.
14:49-58[Medline].
|
| 22.
|
Sartori, A.,
A. V. Oliveira,
M. C. Roque-Barreira,
M. A. Rossi, and A. Campos-Neto.
1987.
Immune complex glomerulonephritis in experimental kala-azar.
Parasite Immunol.
9:93-103[Medline].
|
| 23.
|
Tsunawaki, S.,
M. Sporn,
A. Ding, and C. F. Nathan.
1988.
Deactivation of macrophages by transforming growth factor .
Nature
334:260-262[Medline].
|
Infect Immun, March 1998, p. 1233-1236, Vol. 66, No. 3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dondji, B., Bungiro, R. D., Harrison, L. M., Vermeire, J. J., Bifulco, C., McMahon-Pratt, D., Cappello, M.
(2008). Role for Nitric Oxide in Hookworm-Associated Immune Suppression. Infect. Immun.
76: 2560-2567
[Abstract]
[Full Text]
-
Sen, G., Mukhopadhyay, S., Ray, M., Biswas, T.
(2008). Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity. J Antimicrob Chemother
61: 1066-1075
[Abstract]
[Full Text]
-
Rama Iniguez, S., Dea-Ayuela, M. A., Sanchez-Brunete, J. A., Torrado, J. J., Alunda, J. M., Bolas-Fernandez, F.
(2006). Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum and Treated with a New Amphotericin B Formulation.. Antimicrob. Agents Chemother.
50: 1195-1201
[Abstract]
[Full Text]
-
Mookerjee, A., Sen, P. C., Ghose, A. C.
(2003). Immunosuppression in Hamsters with Progressive Visceral Leishmaniasis Is Associated with an Impairment of Protein Kinase C Activity in Their Lymphocytes That Can Be Partially Reversed by Okadaic Acid or Anti-Transforming Growth Factor {beta} Antibody. Infect. Immun.
71: 2439-2446
[Abstract]
[Full Text]
-
Gantt, K. R., Schultz-Cherry, S., Rodriguez, N., Jeronimo, S. M. B., Nascimento, E. T., Goldman, T. L., Recker, T. J., Miller, M. A., Wilson, M. E.
(2003). Activation of TGF-{beta} by Leishmania chagasi: Importance for Parasite Survival in Macrophages. J. Immunol.
170: 2613-2620
[Abstract]
[Full Text]
-
Murray, H. W.
(2001). Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis. Antimicrob. Agents Chemother.
45: 2185-2197
[Full Text]
-
Melby, P. C., Chandrasekar, B., Zhao, W., Coe, J. E.
(2001). The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response. J. Immunol.
166: 1912-1920
[Abstract]
[Full Text]
-
Gomez-Escobar, N., Gregory, W. F., Maizels, R. M.
(2000). Identification of tgh-2, a Filarial Nematode Homolog of Caenorhabditis elegans daf-7 and Human Transforming Growth Factor beta , Expressed in Microfilarial and Adult Stages of Brugia malayi. Infect. Immun.
68: 6402-6410
[Abstract]
[Full Text]
-
Gomes, N. A., Gattass, C. R., Barreto-de-Souza, V., Wilson, M. E., DosReis, G. A.
(2000). TGF-{beta} Mediates CTLA-4 Suppression of Cellular Immunity in Murine Kalaazar. J. Immunol.
164: 2001-2008
[Abstract]
[Full Text]
-
Alexander, J, Satoskar, A., Russell, D.
(1999). Leishmania species: models of intracellular parasitism. J. Cell Sci.
112: 2993-3002
[Abstract]
-
Wilson, M. E., Young, B. M., Davidson, B. L., Mente, K. A., McGowan, S. E.
(1998). The Importance of TGF-{beta} in Murine Visceral Leishmaniasis. J. Immunol.
161: 6148-6155
[Abstract]
[Full Text]